BioVaxys Technology Corp.
BioVaxys Technology Corp.
BioVaxys Technology Corp. est une société d'immunothérapie au stade clinique développant des plates-formes vaccinales contre le SRAS-CoV-2 et divers cancers.
BioVaxys Technology Corp. (BIOV)
BioVaxys Technology Corp. (BIOV)
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
---|---|---|---|---|---|
W.D. Latimer Co. Limited | 10,000 | 0.045 | 0.05 | 10,000 | Anonymous |
CIBC World Markets Inc. | 10,000 | 0.045 | 0.05 | 100,000 | BMO Nesbitt Burns Inc. |
National Bank Financial Inc. | 1,000 | 0.045 | 0.05 | 30,000 | Questrade Inc. |
Questrade Inc. | 5,000 | 0.04 | 0.05 | 100,000 | National Bank Financial Inc. |
TD Securities Inc. | 1,000 | 0.04 | 0.05 | 12,000 | TD Securities Inc. |
W.D. Latimer Co. Limited | 15,000 | 0.04 | 0.055 | 127,000 | RBC Capital Markets |
BMO Nesbitt Burns Inc. | 1,000 | 0.04 | 0.055 | 30,000 | Questrade Inc. |
RBC Capital Markets | 25,000 | 0.04 | 0.055 | 25,000 | BMO Nesbitt Burns Inc. |
Scotia Capital Inc. | 30,000 | 0.04 | 0.055 | 35,000 | BMO Nesbitt Burns Inc. |
National Bank Financial Inc. | 1,000 | 0.04 | 0.055 | 40,000 | BMO Nesbitt Burns Inc. |
Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
---|---|---|---|---|---|
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 |
Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
---|---|---|---|---|---|
3 | 21,000 | 0.045 | 0.05 | 252,000 | 5 |
9 | 92,000 | 0.04 | 0.055 | 323,000 | 8 |
12 | 264,000 | 0.035 | 0.06 | 62,000 | 6 |
8 | 193,000 | 0.03 | 0.065 | 69,000 | 17 |
4 | 131,000 | 0.025 | 0.07 | 1,104,000 | 7 |
Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
---|---|---|---|---|---|
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
Date/Heure | Prix | Modifier | Volume | Acheteur | Vendeur | Venue |
---|---|---|---|---|---|---|
Apr 16, 19:46 | 0.05 | 0.00 | 49,000 | Anonymous | Anonymous | CSE |
Apr 16, 19:32 | 0.05 | 0.00 | 10,000 | CIBC World Markets Inc. | CIBC World Markets Inc. | CSE |
Apr 16, 18:41 | 0.05 | 0.00 | 73,000 | RBC Capital Markets | Anonymous | CSE |
Apr 16, 18:31 | 0.05 | 0.00 | 10,000 | Raymond James Ltd. | Anonymous | CSE |
Apr 16, 18:28 | 0.045 | -0.005 | 9,000 | Raymond James Ltd. | Anonymous | CSE |
Information d'entreprise
SEDAR Information
Information d'entreprise
Capitalisation
Company Officers
Bulletins
2024-0715 - Réintégration - BioVaxys Technology Corp. (BIOV)
le 16 juillet/July 2024
Effective immediately, BioVaxys Technology Corp. will be reinstated for trading.
The Company has rectified the situation that gave rise to the suspension.
____________________________
Avec effet immédiat, BioVaxys Technology Corp. sera réintégrée à la négociation.
La Société a rectifié la situation qui a donné lieu à la suspension.